期刊文献+

腹膜透析患者发生难治性甲状旁腺功能亢进的相关因素分析 被引量:2

Risk factor analysis of refractory secondary hyperparathyroidism in patients undergoing continuous ambulatory peritoneal dialysis
下载PDF
导出
摘要 目的:探讨引起腹膜透析患者的难治性甲状旁腺功能亢进(SHPT)的相关因素。方法:分析2015年11月~2018年5月于我院行甲状旁腺切除术的51例腹膜透析患者临床资料,并与我院同期50例甲状旁腺激素<300pg/ml的腹膜透析患者进行比较,对发生难治性SHPT的相关因素:血钙、血磷、血白蛋白及透析龄、透析液种类、合并糖尿病情况以及开始检测iPTH的时间等进行逻辑回归分析。结果:2组血钙、血磷、透析龄、血白蛋白、开始检测iPTH的时间均存在显著性差异(P<0.01,P<0.05)。行手术的难治性甲状旁腺功能亢进组患者开始检测iPTH的时间,明显晚于甲状旁腺激素在300pg/ml以下的腹膜透析患者(P<0.01)。回归分析显示,透析龄长、高血磷、开始检测iPTH时间等均是腹膜透析患者发生难治性SHPT的风险因素。结论:腹膜透析患者高透析龄、高血磷、开始检测iPTH晚等是其发展为难治性SHPT的风险因素。 Objective:To investigate the risk factors of refractory secondary hyperparathyroidism (SHPT)in patients with continuous ambulatory peritoneal dialysis (CAPD).Methods:The study enrolled 101patients with CAPD,fifty-one cases of whom were diagnosed as refractory SHPT and underwent parathyroidectomy in recent two and a half years in our hospital.The other 50cases were CAPD patients in our hospital,whose intact parathyroid hormone (iPTH)were well controlled (lower than 300pg/ml).Logistic regression analysis was performed on the clinical data of two groups to analyze the influence factors of refractory SHPT in CAPD patients.Results :There were significant differences in the levels of serum calcium,phosphorus,dialysis vintage and serum albumin between the two groups (P<0.01,P<0.05).The use ratio of low-calcium peritoneal dialysis solution,the time to start iPTH testing were significantly different between the two groups(P<0.01).Logistic regression analysis showed that the dialysis vintage,blood phosphate and the time of start iPTH testing were influence factors of refractory SHPT in CAPD patients.Conclusion:High dialysis vintage,high blood phosphate level and late detection of iPTH may be the risk factors for developing refractory SHPT in CAPD patients.
作者 徐志宏 董敏 李艳博 邢淑宁 张凌 金承刚 李文歌 XU Zhi-hong;DONG Min;LI Yan-bo(Department of Nephrology,China-Japan Friendship Hospital,Beijing 100029,China)
出处 《中日友好医院学报》 2018年第6期327-329,333,共4页 Journal of China-Japan Friendship Hospital
关键词 腹膜透析 难治性继发性甲状旁腺功能亢进 peritoneal dialysis refractory secondary hyperparathyroidism
  • 相关文献

参考文献3

二级参考文献36

  • 1<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 2陈香美,王海燕.提高慢性肾脏病的知晓率、治疗率和控制率减轻对国民健康的危害[J].中华内科杂志,2006,45(6):441-442. 被引量:64
  • 3张训.血液透析患者血管钙化的防治[J].中国血液净化,2007,6(5):233-235. 被引量:16
  • 4Eknoyan G,Lameire N,Barsoum R,et al.The burden of kidney disease:Improving global outcomes[J].Kidney Int,2004,66:1310-1314.
  • 5Kidney Disease:Improving Global Outcomes (KDIGO) CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J].Kidney Int,2009,76(Suppl 113):1-130.
  • 6Toshitsugu Sugimoto,Cynthia Ritter,Jeremiah Morrissey,et al.Effects of high concentrations of glucose on PTH secretion in parathyroid cells[J].Kidney Int,1990,37:1522-1527.
  • 7F.J.A.Paula,C.M.M.Lanna,T.Shuhama,et al.Effect of metabolic control on parathyroid hormone secretion in diabetic patients[J].Braz J Med Biol Res,2001,34:1139-1145.
  • 8National Kidney Foundation.K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease[J].Am J Kidney Dis,2003,42(4,Suppl3):S1-201.
  • 9Michiko Hori1,Yoshifumi Ubara1,Shohei Nakanishi,et al.Hyperparathyroidism in a diabetic patient on dialysis[J].NDT Plus,2008,1:361-362.
  • 10Nechama M,Ben-Dov IZ,Silver J,et al.Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD[J].Am J Physiol Renal Physiol,2009,296:795-800.

共引文献51

同被引文献22

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部